Switzerland sees a rise in measles cases, aligning with global trends despite high vaccination rates.

Switzerland's National Council advances legislation to prohibit the sale of electronic disposable cigarettes, citing environmental and health concerns.

Die begrenzte Legalisierung von Marihuana in Deutschland hat zu einer Vielzahl von Diskussionen und Veränderungen im gesellschaftlichen und rechtlichen Rahmen geführt.

Two-thirds of Swiss citizens support abolishing current health insurance companies in favor of a single state fund, seeking lower premiums and digital advancements.

The federal government plans new addiction support centers to address the rising crack cocaine problem.

Swiss Hearing Aid Firm Misenso, owned By Migros Group is to be sold to a Swiss ear specialist firm.

Health insurance premiums in Switzerland surpass CHF 10,000. Doctors criticize patient behaviors, and the Federal Council debates postal service changes.

Swiss men and women consume significantly more salt than recommended, with men particularly exceeding safe limits.

Support for both healthcare proposals in Switzerland has decreased ahead of the June 9 vote, with the cost brake initiative trending towards a "no" and the premium relief initiative showing a narrow "yes.

Federal statistical office reports rising work stress, impacting 23% of the workforce.

Galenica sees robust sales growth across all sectors, driven by strong pharmaceutical market.

Swixx BioPharma significantly expands its market reach in Latin America by acquiring Biopas, enhancing its presence in neurology, oncology, and other therapeutic areas.

Since 2019, the tiger mosquito has expanded its presence in Valais, reaching new areas in 2023.

Swiss agriculture sees a modest growth in organic farming, with a significant shift in land use amidst overall farm decline.

Switzerland achieves a historic high in organ donations and transplants, offering new hope to many on the waiting list.

After half a century, the Anopheles sacharovi mosquito, capable of spreading malaria, has been detected in Apulia, Italy.

After a dip in 2022, Sanitas Group bounces back with a strong profit in 2023 and significant growth in policyholder numbers.

Early polling indicates Swiss voters are likely to approve initiatives on healthcare cost control and energy tax waivers, with significant support varying across demographic lines.